Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: IRADIMED CORPORATION

Market Cap 1.18B 1.03B 953M 889M 1.67B 111B 1.68B 11.32B 4.4B 54.76B 4.43B 4.33B 190B P/E 2026 *
48.3x
P/E 2027 * 42.6x
Enterprise Value 1.18B 1.03B 953M 889M 1.67B 111B 1.68B 11.32B 4.4B 54.76B 4.43B 4.33B 190B EV / Sales 2026 *
12.9x
EV / Sales 2027 * 11.7x
Free-Float
64.8%
Yield 2026 *
-
Yield 2027 * -
1 day-1.16%
1 week+0.13%
Current month+0.27%
1 month-1.30%
3 months-8.36%
6 months-6.41%
Current year-6.55%
1 week 89.69
Extreme 89.69
97.73
1 month 87.91
Extreme 87.91
98.41
Current year 76.95
Extreme 76.95
107.9
1 year 55.11
Extreme 55.1093
107.9
3 years 36.12
Extreme 36.12
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 28/05/2020
Director of Finance/CFO 64 20/06/2022
Chief Tech/Sci/R&D Officer - 01/01/2020
Director TitleAgeSince
Chairman 72 16/06/2020
Director/Board Member 70 01/01/2019
Director/Board Member 73 01/01/2014
Date Insider Type Main position Quantity % Market Cap.
06-04Sell

Director

-3,000 0.0235%
06-01Sell

Chief Executive Officer

-2,500 0.0196%
05-27Sell

Chief Executive Officer

-2,500 0.0196%
Change 5-day change 1-year change 3-year change Capi.($)
-1.19%+0.13%+52.79%+90.58% 1.18B
+0.69%-8.62%-18.89%-22.11% 12.54B
-8.11%-1.02%+77.83%+14.86% 5.27B
-0.94%-4.36%-36.83%-65.12% 1.21B
-1.66%-2.59%-33.78%-43.62% 1.19B
+0.20%-3.41%-37.61% - 949M
-5.50%-7.12%+196.15%+185.79% 704M
-1.51%-10.30% - - 330M
-2.42%-2.96%-58.48%+192.75% 247M
-1.56%+14.13%+127.04%-30.92% 159M
Average -2.23%-2.84%+29.80%+40.28% 2.38B
Weighted average by Cap. -1.84%-6.22%+11.03%-2.20%

Financials

2026 *2027 *
Net sales 91.2M 79.69M 73.71M 68.8M 129M 8.62B 130M 876M 341M 4.24B 342M 335M 14.72B 101M 88.17M 81.55M 76.12M 143M 9.54B 144M 969M 377M 4.69B 379M 371M 16.29B
Net income 24.55M 21.45M 19.84M 18.52M 34.77M 2.32B 35.02M 236M 91.75M 1.14B 92.17M 90.17M 3.96B 27.8M 24.29M 22.47M 20.97M 39.37M 2.63B 39.66M 267M 104M 1.29B 104M 102M 4.49B
Net Debt - -
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
22/06/26 90.82 $ -1.50% 26,760
18/06/26 92.20 $ +1.22% 182,287
17/06/26 91.09 $ -0.82% 121,914
16/06/26 91.84 $ +1.16% 132,802
15/06/26 90.79 $ -3.00% 158,204
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
92.20USD
Average target price
118.00USD
Spread / Average Target
+27.98%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!